Table 6.
Parameters | Control group at 36th week | Study group at 36th week | ||
---|---|---|---|---|
r value | p value | r value | p value | |
BMI | –0.045 | 0.398 | 0.013 | 0.867 |
HR | 0.109 | 0.185 | 0.120 | 0.114 |
SBP | –0.145 | 0.095 | 0.090 | 0.235 |
DBP | –0.102 | 0.197 | 0.077 | 0.310 |
RPP | –0.152 | 0.085 | 0.193 | 0.010 |
RM | 0.115 | 0.157 | 0.151 | 0.045 |
TP | 0.108 | 0.186 | –0.167 | 0.027 |
LFnu | 0.099 | 0.192 | 0.235 | 0.002 |
HFnu | 0.053 | 0.286 | –0.140 | 0.064 |
LF–HF ratio | –0.098 | 0.217 | 0.184 | 0.014 |
HbA1C | 0.110 | 0.175 | 0.336 | < 0.001 |
MDA | –0.103 | 0.195 | 0.410 | < 0.001 |
hsCRP | –0.083 | 0.213 | 0.109 | 0.149 |
IL-6 | –0.110 | 0.183 | 0.428 | < 0.001 |
NO | 0.154 | 0.088 | –0.381 | < 0.001 |
EPDS | 0.198 | 0.024 | 0.582 | < 0.001 |
QoL | 0.162 | 0.048 | –0.299 | < 0.001 |
IRDS | –0.095 | 0.220 | 0.195 | 0.009 |
The p value < 0.05 was considered significant; r: correlation coefficient.
PSS perceived stress scale, BMI body mass index, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, RPP rate pressure product, RM resting metabolism, TP total power of HRV, LFnu low-frequency power normalized, HFnu high-frequency power normalized, LF–HF ratio of LF to HF, HbA1C glycated hemoglobin, MDA malondialdehyde, hsCRP high sensitive c-reactive protein, IL-6 interleukin-6, NO nitric oxide, EPDS Edinburgh postnatal depression scale, QoL quality of life, IRDS Indian diabetic risk score.